TRC

TRC TRC has over 40 years specialised in the production of quality products for innovative research.

09/15/2026

How do assigned values, measurement uncertainty, and traceability contribute to confidence in pharmaceutical testing?

Join our upcoming webinar "Working Standards in Pharmaceutical Quality Control" to explore the science behind working standards and discuss practical strategies for establishing, qualifying, and managing them in routine pharmaceutical quality control.

What you'll learn:
✅ Approaches to establishing and qualifying working standards for compendial and non-compendial testing
✅ Practical considerations for lifecycle management and outsourcing
✅ Insights from a real-world customer case study
✅ LGC's API working standard solutions

📅 15 October 2026
14:00 BST | 15:00 CEST | 09:00 EDT | 06:00 PDT

⏳ Register early to secure your place: https://ow.ly/AxP050ZNc3u

09/09/2026

Have we made progress in managing nitrosamines?

In this clip from our expert panel discussion, panellists Jason Brown and Dr Joerg Schlingemann
reflect on how far the industry has come in recent years, from advances in process understanding and formulation science to significant developments in toxicology and nitrosamine risk assessment.

Yet despite this progress, important challenges remain, particularly around regulatory alignment and implementation.

🎥 Want to hear more?
This on-demand panel discussion brings together five leading experts from industry, academia and regulatory science to explore the science, regulation and practical management of nitrosamines.

Watch on demand now: 🔗 https://ow.ly/pEUo50ZF3Lv

09/03/2026

🗨️"If we had been using an isotopically labelled standard, it would have 100% been avoided."

In this clip from our expert panel discussion, Jason Brown, Principal Consultant at Brown Pharma Consulting Ltd, shares a real-world example where the use of an isotopically labelled standard could have prevented a false negative result.

💡His experience highlights the importance of robust analytical approaches and why stable isotope-labelled standards can be critical for building confidence in nitrosamine testing.

🎥 Want to hear more?
This on-demand panel discussion brings together five leading experts from industry, academia and regulatory science to explore the science, regulation and practical management of nitrosamines.

Register to watch on demand: 🔗 https://ow.ly/4tvz50ZESMr

💊GLP-1 agonist-based therapies have taken the world by storm in 2026.As weight loss treatments, they're already achievin...
09/02/2026

💊GLP-1 agonist-based therapies have taken the world by storm in 2026.
As weight loss treatments, they're already achieving remarkable sales in developed countries - while new dosage forms are expected to accelerate demand all around the world.

👩‍🔬Even more exciting, GLP-1s are showing promise for tackling a wide range of other ailments - including cancer, addiction, Alzheimer's, heart attacks, strokes, kidney disease, and more.

👇Our focused selection of GLP-1 research compounds is now available to support your method development, assay optimisation, and reference testing needs. It features:

✅semaglutide,
✅liraglutide,
✅exenatide acetate,
✅exenatide d5 acetate,
✅lixisenatide acetate, and
✅tirzepatide.

⬇️Explore the range: https://ow.ly/39Xo50ZGs2J

08/27/2026

Have you seen divergence between regulatory agencies on how they interpret acceptable impurity limits? 💬

In this clip from our expert panel discussion, Jörg Schlingemann, nitrosamine expert and consultant, discusses a recent example highlighting how regulatory expectations can vary between regions.

Drawing on a discussion with the Thai FDA, he explores how different interpretations of maximum daily dose can influence acceptable intake calculations for nitrosamines, creating challenges for companies preparing global submissions.

🎥 Want to hear more?
This on-demand panel discussion brings together five leading experts from industry, academia and regulatory science to explore the science, regulation and practical management of nitrosamines.

Register to watch on demand: 🔗 https://ow.ly/9NV650ZEOIt

08/20/2026

Where do ICH M7, FDA and EMA expectations stand today, and where are the remaining grey areas? 💬

In this clip from our expert panel discussion, Dr George Johnson, Associate Professor at Swansea University discusses one of the key challenges facing the pharmaceutical industry: the gap that can exist between scientific consensus and regulatory acceptance while guidance continues to evolve.

🎥 Want to hear more?
This on-demand panel discussion brings together five leading experts from industry, academia and regulatory science to explore the science, regulation and practical management of nitrosamines.

Register to watch on demand: 🔗 https://ow.ly/Jgh650ZBSOo

Can we predict the safety of extractables and leachables before testing every compound?📜 A new collaborative study invol...
08/18/2026

Can we predict the safety of extractables and leachables before testing every compound?

📜 A new collaborative study involving scientists from the FDA has analysed the chemical space of more than 1,200 pharmaceutical extractables and leachables, providing one of the most comprehensive overviews of these compounds to date. ( https://ow.ly/CIPf50ZAY0J )

💡The significance isn't simply the size of the dataset. By grouping structurally similar compounds and examining existing toxicity data, the work provides a stronger scientific foundation for read-across, helping toxicologists assess the safety of previously uncharacterised leachables more efficiently and consistently.

As extractables and leachables guidance continues to evolve, this type of evidence-based approach has the potential to make risk assessments more efficient while maintaining confidence in patient safety.

At LGC Standards, we support extractables and leachables workflows with a comprehensive portfolio of analytical reference standards for method development, identification and quantification. Explore the range: https://ow.ly/5a8w50ZAY0K

👋Calling all researchers: we want to hear your ideas about tackling emerging contaminants! Whether they’re PFAS or PCBs,...
08/14/2026

👋Calling all researchers: we want to hear your ideas about tackling emerging contaminants!

Whether they’re PFAS or PCBs, microplastics or flame retardants, we’re interested in innovative ways of dealing with them – from detection and monitoring to risk assessment and mitigation.

📨Enter our poster competition by submitting an abstract of up to 200 words, explaining how your ideas can help defend our water, soil, air and food chain.

All abstracts will then be reviewed by an expert panel, and shortlisted entries presented at a virtual webinar next year.

🏆Prizes include up to £2,000 worth of reference standards to support future research, and Amazon eGift cards worth up to £200 for the winner.

Deadline: October 14, 2026.

✍️Sign up for the competition: https://ow.ly/NfYc50ZyQcQ

Many factors influence the reported API potency result.From sample preparation and reference standards to instrument per...
08/13/2026

Many factors influence the reported API potency result.

From sample preparation and reference standards to instrument performance and method validation, every stage of the assay can affect the final result. Understanding these sources of variation is essential for generating accurate and reliable potency data.

💡Our latest application note explores sources of systematic bias in LC–UV potency assays and practical strategies to minimise them.

⬇️ Download the application note: https://ow.ly/EvhX50ZxGO6

08/11/2026

Our quality reference standards can help your lab to meet strict regulatory limits on NDSRIs and small molecule nitrosamines around the world.

We offer:
✔️650+ NDSRI compounds for major therapeutic areas (e.g. neuroscience, oncology, metabolic disorders),
✔️90+ small molecule nitrosamine reference materials (including NDMA, NDEA, NMBA and DIPNA),
✔️Active development pipelines (150+ NDSRIs in progress and new products released monthly),
✔️Rapid, responsive custom synthesis,
✔️Varied formats, including neats, ready-to-use solutions, plus native and labelled standards,
✔️Multiple quality levels to suit the nature of your work.

Discover more: https://ow.ly/VhSI50ZxHAW

Address

20 Martin Ross Avenue
Toronto, ON
M3J2K8

Website

Alerts

Be the first to know and let us send you an email when TRC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category